Global Blood Therapeutics Inc
(London Stock Exchange, The : GBT)

( )
GBT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.38%194.911.2%$602.16m
GILDGilead Sciences, Inc.
-0.78%67.480.9%$499.30m
CELGCelgene Corporation
-0.19%69.271.2%$492.42m
BIIBBiogen Inc.
0.01%319.251.3%$467.66m
ILMNIllumina, Inc.
-5.73%301.593.5%$381.70m
REGNRegeneron Pharmaceuticals, Inc.
0.00%338.982.6%$298.66m
VRTXVertex Pharmaceuticals Incorporated
-2.45%161.071.9%$260.54m
ALXNAlexion Pharmaceuticals, Inc.
-3.00%115.062.0%$199.08m
AAgilent Technologies, Inc.
-3.72%62.571.5%$185.86m
SRPTSarepta Therapeutics, Inc.
-2.25%116.3615.4%$146.77m
LGNDLigand Pharmaceuticals Incorporated
-3.83%148.5423.3%$139.57m
EXASExact Sciences Corporation
0.00%67.2825.3%$137.02m
NKTRNektar Therapeutics
-0.05%37.995.6%$122.18m
INCYIncyte Corporation
-3.40%64.252.5%$115.74m
TSROTESARO, Inc.
-0.41%36.6814.4%$108.95m

Company Profile

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.